A medical cannabis ETF would have been "impossible" to launch five years ago and, to this day, remains "one of those edgier subjects", according to co-founder of Rize ETF Rahul Bhushan. To get it past the depositories, the administrators, the legal and regulatory issues, let alone getting it signed off by the investment committee… At Legal & General would have taken us six decades, not six months, to launch that product," he said. The team hoped the Rize Medical Cannabis and Life Sciences UCITS ETF would "really put us on the map" with a "new, innovative and exciting" product that sho...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes